New York State Common Retirement Fund Ventyx Biosciences, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2025	BUY	$1.85 - $3.2 $35,101 - $60,716	18,974 New	18,974 $41,000
Q2 2024 Oct 08, 2025	BUY	$2.31 - $5.59 $43,829 - $106,064	18,974 New	18,974 $43,000
Q2 2024 Jul 31, 2024	BUY	$2.31 - $5.59 $55 - $134	24 Added 0.13%	18,974 $44,000
Q1 2024 Oct 08, 2025	BUY	$1.9 - $10.13 $36,005 - $191,963	18,950 New	18,950 $104,000
Q1 2024 May 07, 2024	SELL	$1.9 - $10.13 $106 - $567	-56 Reduced 0.29%	18,950 $104,000

Q4 2023 Oct 08, 2025	BUY	$2.08 - $31.18 $39,532 - $592,607	19,006 New	19,006 $46,000
Q4 2023 Feb 01, 2024	SELL	$2.08 - $31.18 $137 - $2,057	-66 Reduced 0.35%	19,006 $47,000
Q3 2023 Oct 08, 2025	BUY	$29.8 - $40.3 $568,345 - $768,601	19,072 New	19,072 $662,000
Q3 2023 Nov 07, 2023	BUY	$29.8 - $40.3 $8,820 - $11,928	296 Added 1.58%	19,072 $662,000
Q2 2023 Oct 08, 2025	BUY	$28.53 - $39.55 $535,679 - $742,590	18,776 New	18,776 $615,000
Q2 2023 Aug 07, 2023	BUY	$28.53 - $39.55 $156,429 - $216,852	5,483 Added 41.25%	18,776 $616,000
Q1 2023 Oct 08, 2025	SELL	$29.51 - $46.65 $64,095 - $101,323	-2,172 Reduced 14.04%	13,293 $445,000
Q1 2023 May 02, 2023	SELL	$29.51 - $46.65 $64,095 - $101,323	-2,172 Reduced 14.04%	13,293 $445,000
Q4 2022 Oct 08, 2025	BUY	$24.16 - $36.38 $373,634 - $562,616	15,465 New	15,465 $507,000
Q4 2022 Jan 30, 2023	SELL	$24.16 - $36.38 $103,573 - $155,961	-4,287 Reduced 21.7%	15,465 $507,000
Q3 2022 Nov 08, 2022	BUY	$12.64 - $38.7 $94,850 - $290,404	7,504 Added 61.27%	19,752 $690,000
Q2 2022 Aug 04, 2022	BUY	$11.95 - $18.75 $82,132 - $128,868	6,873 Added 127.87%	12,248 $150,000
Q1 2022 May 05, 2022	BUY	$10.0 - $19.98 $53,750 - $107,392	5,375 New	5,375 $73,000

Others Institutions Holding VTYX

# of Institutions

122

Shares Held

48.5M

Call Options Held

152K

Put Options Held

43.8K

Black Rock Inc. New York, NY

4.77M
Shares

$44.1 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

3.92M
Shares

$36.3 Million
1.42% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$34.9 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3.21M
Shares

$29.7 Million
0.02% of portfolio
Tang Capital Management LLC San Diego, CA

3.1M
Shares

$28.7 Million
0.44% of portfolio

View Full List

About Ventyx Biosciences, Inc.

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $523M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

More about VTYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account